logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10647963 B1

PDFFull Text
Date of Patent:
May. 12, 2020

Filed:

Apr. 16, 2014

Enhanced adoptive cell therapy

Applicant:

Tilt Biotherapeutics Oy, Helsinki, FI;

Inventors:

Akseli Hemminki, Helsinki, FI;

Markus Vaha-Koskela, Masala, FI;

Siri Tahtinen, Helsinki, FI;

Vincenzo Cerullo, Helsinki, FI;

Assignee:

TILT BIOTHERAPEUTICS OY, Helsinki, FI;

Attorney:

Birch, Stewart, Kolasch & Birch, LLP

Primary Examiner:

Thaian N Ton

Int. Cl.
CPC ...
C12N 7/00 (2006.01); A61K 35/17 (2015.01); C07K 14/525 (2006.01); A61K 35/76 (2015.01); C07K 14/47 (2006.01); A61K 35/761 (2015.01); C07K 14/55 (2006.01); C07K 14/565 (2006.01); C07K 14/57 (2006.01); C07K 14/52 (2006.01); C12N 15/86 (2006.01); A61K 48/00 (2006.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
C12N 7/00 (2013.01); A61K 35/17 (2013.01); A61K 35/76 (2013.01); A61K 35/761 (2013.01); C07K 14/472 (2013.01); C07K 14/52 (2013.01); C07K 14/525 (2013.01); C07K 14/55 (2013.01); C07K 14/565 (2013.01); C07K 14/57 (2013.01); C12N 15/86 (2013.01); A61K 48/00 (2013.01); A61K 2035/124 (2013.01); C12N 2710/10032 (2013.01); C12N 2710/10041 (2013.01); C12N 2710/10043 (2013.01);
Abstract

The present invention relates to the fields of life sciences and medicine. Specifically, the invention relates to cancer therapies of humans. More specifically, the present invention relates to oncolytic adenoviral vectors alone or together with therapeutic compositions for therapeutic uses and therapeutic methods for cancer. In one aspect the present invention relates to separate administration of adoptive cell therapeutic composition and oncolytic adenoviral vectors. Furthermore, the present invention relates to a pharmaceutical kit and a pharmaceutical composition, both utilizing oncolytic adenoviral vectors.

Find Patent Forward Citations

Loading…